These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23200885)

  • 1. Measurement uncertainty for serum free light chain assays: estimation and implication on result interpretation.
    Wang L; Chan PC
    Clin Biochem; 2013 Mar; 46(4-5):381-4. PubMed ID: 23200885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum free light chain reference values: a critical approach.
    Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M
    Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
    Fulton RB; Fernando SL
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analysis using extended renal reference range of serum free light chain ratio and serum protein electrophoresis improves the diagnostic accuracy of multiple myeloma in renal insufficiency.
    Park JW; Kim YK; Bae EH; Ma SK; Kim SW
    Clin Biochem; 2012 Jul; 45(10-11):740-4. PubMed ID: 22503879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological variation of immunoglobulin heavy chain-light chain pairs in serum.
    Finlay JA; Wu AH
    Clin Chim Acta; 2014 Sep; 436():68-71. PubMed ID: 24824555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum free light chain analysis: persisting limitations with new kids on the block.
    Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
    Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathy.
    Wolff F; Debaugnies F; Rozen L; Willems D; Brohet F; Brauner J; Stordeur P
    Clin Biochem; 2013 Jan; 46(1-2):79-84. PubMed ID: 23041246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of light chains in serum].
    Hansen CT; Nielsen L; Münster AM; Abildgaard N
    Ugeskr Laeger; 2010 Aug; 172(34):2302-5. PubMed ID: 20727297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free light chains; the need to establish local reference intervals.
    Pattenden RJ; Rogers SY; Wenham PR
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):512-5. PubMed ID: 17961304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review.
    Charafeddine KM; Jabbour MN; Kadi RH; Daher RT
    Am J Clin Pathol; 2012 Jun; 137(6):890-7. PubMed ID: 22586047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: correlation with 24-hr urinary light-chain excretion.
    Alyanakian MA; Abbas A; Delarue R; Arnulf B; Aucouturier P
    Am J Hematol; 2004 Apr; 75(4):246-8. PubMed ID: 15054820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
    Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
    Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect.
    Shaheen SP; Levinson SS
    Clin Chim Acta; 2009 Aug; 406(1-2):162-6. PubMed ID: 19410572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving use of serum free light chain assays in haematology.
    Pratt G
    Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurement of immunoglobulins and free light chains using mass spectrometry.
    VanDuijn MM; Jacobs JF; Wevers RA; Engelke UF; Joosten I; Luider TM
    Anal Chem; 2015 Aug; 87(16):8268-74. PubMed ID: 26168337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
    Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
    Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
    Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overestimation of free light chain antigen excess rate.
    Vercammen MJ; Broodtaerts L; Meirlaen P; Bossuyt X
    Clin Chim Acta; 2015 Apr; 444():297-302. PubMed ID: 25745855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.